Urogen pharma ltd.

Major-Pharmaceuticals

URGN


499 Park Avenue
New York , NY 10014

Executive/
Director

Price

  • Last Close
  • $ 12.17
    $ -1.85 -13.17 %
    Dec 9, 2024
  • 52-Week High/Low
  • $19.33 - $10.87
  • YTD
  • -18.9%

  • Trading Volume
  • 9,288
  • Market Cap Full
  • $ 375.6M
  • Shares Outstanding
  • 30.9M
    Nov 7, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - 33.5% -14.2% -5% 8.1% -8.4% 4.2% -
Q2 - - 29.2% 2.9% -7.1% 4% -21.6% -6% 12% -0.8%
Q3 - - 74.5% -6.7% -36.1% 8% 10.2% 1.6% 35.4% -
Q4 - - 15.7% -10% 42.5% -6.6% -43.5% 6.6% 9.6% -
J F M A M J J A S O N D
2024 4.7% 16.8% -18.2% -6.1% - - - - - - - -
2023 17.1% -0.9% -10.3% 25.4% -14.6% 4.6% 109.3% -19.3% -19.9% -20% 17.7% 13.7%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%16%-21%-47%-47%-7%69%-19%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - - -0.88 -1.11 -1.79 -1.17 -1.25 -1.30
Q2 - - 0.70 -1.14 -1.08 -1.44 -1.17 -1.18 -1.03
Q3 - - 0.02 -1.28 -1.06 -1.31 -1.35 -1.13 -0.68
Q4 - - 0.74 -1.5 -1.87 -1.36 -1.27 -1.25 -
A 0 0 1.5 -4.8 -5.1 -5.9 -5 -4.8 -3.01

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2019 2020 2021 2022 2023
Mar 20.5 21.2 22.3 22.7 23.4
Jun 20.8 21.9 - 22.7 23.5
Sep 20.9 22 22.4 22.7 30.3
Dec 21 22.1 22.4 23.1 30.9

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 2 1 0.5 - -
Fixed Asset Turnover 16 9.6 3 - 1
Total Asset Turnover 0.5 0.4 0.1 - -
Leverage
Debt Ratio 0.8 - - - -
Debt – Equity Ratio -1.1 - - - -
Interest Coverage -2.6 -4.8 -127 27.3 77
Equity multiplier - 0.6 - 0.3 -